Matt Harmon

In this engaging discussion, John Zutter, CEO of Lantern, and Matt Harmon, a benefits executive veteran, delve into the skyrocketing costs of healthcare. They explore how large employers are tackling expensive treatments like cell and gene therapies. The duo discusses the rise of centers of excellence to direct patients towards quality care, the challenges faced by small employers in covering costly therapies, and the balance between employee choice and employer strategy. Their insights reveal the complex landscape of healthcare spending today.